FOXO4-DRI (FOXO4)

Senolytic peptide that selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 interaction.

Key Data

Research Status

Early research

Half-Life

Unknown

Administration

Subcutaneous injection

Typical Dosage

Research varies

Mechanism of Action

D-retro-inverso peptide that interferes with FOXO4-p53 binding in senescent cells, triggering their apoptosis.

Reported Benefits

• Senescent cell clearance
• Tissue rejuvenation
• Anti-aging potential
• Reduced inflammation

All information is presented for Research Use Only (RUO). Not medical advice.